A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients

NCT03654196 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bronchitis

Interventions

DRUG: HL301(Experimental)
DRUG: Umkamin(Active Comparator)

Sponsor

Hanlim Pharm. Co., Ltd.